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Summary.-Three hundred and eighty-two patients undergoing thymectomy for
myasthenia gravis at4 London hospitals during the years 1942-64 have been followed
to the end of 1967. Five of these patients died from extrathymic tumours while 5-5
would have been expected to do so from the national experience. An additional
5 patients developed non-fatal extrathymic tumours during the period of follow-up.
These data provide no evidence that adult thymectomy is followed by an increased
risk of neoplastic disease, but more prolonged follow-up will be required before a
final conclusion can be drawn.
In 1959, Thomas suggested that the
phenomenon ofhomograft rejection might
represent a mechanism for natural defence
against neoplastic disease. By this he
implied that there was an immuno-
logical system for recognizing and eli-
minating malignant cells arising within
the body, a concept that was developed
by Burnet (1970) and characterized as
"immunological surveillance".
If the body does possess natural
immunologicaldefencemechanismsagainst
cancer, there is good reason to believe that
the thymus will play an important part in
them. In 1961, Miller first showed that
thymectomy of newborn mice results in
depletion ofthe lymphocyte population of
the blood and lymphoid tissues, an
inability to reject foreign skin grafts, andi
premature death attributed to infection.
Since that time, it has been shown in a
number of species that neonatal thymec-
tomy impairs immune reactions mediated
by small lymphocytes, such as transplan-
tation immune reactions (Miller, 1962)
and delayed sensitivity reactions (Arnason
et al., 1962). The humoral antibody
responses to most antigens are not affected
and immunoglobulin production is not
impaired (Faheyetal., 1965). Thethymus
is thus concerned with the type ofreaction
which may be ofimportance in "inmuno-
logical surveillance".
Thymectomy in adult rodents was
originally thought to be without any
important effect, but it was subsequently
shown to be followed by a decline in
immunological capacity which becomes
apparent only after a period of 6-9
months (Miller, 1965; Metcalf, 1965;
Taylor, 1965). From this finding it was
concluded that the adult thymus in-
fluences the development of a population
of immunologically competent cells which
are long lived, and that only when this
pool has been depleted do defects in
immune capacity become apparent (Miller,
1965).
A number of studies have indicated
that thymectomy renders mice more sus-
ceptible to the carcinogenic activity of
oncogenic viruses and certain chemical
carcinogens. For example, Miller et al.
(1963) found increased activity of a
carcinogenic hydrocarbon in producing
skin cancer in mice thymectomized at 3
days of age when compared with sham
operated controls, while Gaugus et al.
(1969) reported that 100% of mice
thymectomized at 6 weeks of age and
treated with antilymphocytic serum deve-
loped tumours of various types, thoughtMARTIN P. VESSEY AND SIR RICHARD DOLL
to be due to polyoma virus. Tumours
induced by oncogenic viruses and chemical
carcinogens have been shown to possess
distinct cellular antigens which can evoke
a homograft tvpe ofreaction. The growth
of these antigenic tumours is thus facili-
tated by inadequacy of transplantation
immune reactions.
Information concerning the role of the
thymus in man in adult life is sparse.
Absence of the thymus is associated with
gross defects of the immunological system
(Lischner and DiGeorge, 1969), but infants
with this defect have not survived suffi-
ciently long to show what effect this might
have in adult life. In adults, only
patients with myasthenia gravis (with or
without thymoma) have been subjected
to thymectomy in any number and studies
of the immunological status of such
patients are both few and confusing.
For example, Kornfeld et al. (1965)
foutnd a normal primary response to
H-agglutinin after triple typhoid vaccina-
tion in both thymectomized and non-
thymectomized myasthenics, but found
evidence of an impaired secondary re-
sponse after later challenge. The impair-
ment was greater in thymectomized than
in non-thymectomized patients, but the
authors were uncertain whether removal
of the thymus or the greater severity of
the disease in patients who had come to
operation was responsible for the differ-
ence. They were unable to find any
impairment of established delayed hyper-
sensitivity to a variety of antigens, or
induced hypersensitivity to dinitrochloro-
benzene. Adner et al. (1964), on the other
hand, found a diminished capacity among
their myasthenic patients, both thymecto-
mized and non-thymectomized, to acquire
dinitrochlorobenzene sensitivity.
Although a number offollow-up studies
of patients subjected to thymectomy for
myasthenia gravis have been reported (see
discussion), they have been concerned
principally with the response of the
disease to the operation rather than with
the cancer risk among the survivors.
Accordingly, we thought it would be
worthwhile identifying a large group of
thymectomized myasthenics and following
them up to find out how many subse-
quently died from extrathymic malignant
disease. The results of this investigation
form the subject of the present report.
MATERIAL AND METHODS
A total of 423 patients who underwent
thymectomy for myasthenia gravis between
January 1, 1942, and December 31, 1964, at
4 London hospitals (the National Hospital for
Nervous Diseases, New End Hospital, St
Bartholomew's Hospital and the London
Hospital) were identified from diagnostic
indexes and operating theatre books. Four
patients could not be studied further because
their case records had been lost, but every
effort was made to follow the remaining 419
to December 31, 1967. Death certificates
w%Aere obtained for those who had died, and the
causes of death were classified according to
the Seventh Revision of the International
Classification of Diseases (World Health
Organization, 1957). Special enquiries were
made about all patients certified as dying
from an extrathymic tumour and information
was also sought about the occurrence of
non-fatal tumours by searching all available
case records and by corresponding with
general practitioners.
Thirty-six ofthe 419 patients were foreign
nationals who had come to Britain for the
operation. These patients are not con-
sidered further here, but we may note that
none ofthe 29 who were successfully followed
to December 31, 1967, had, so far as we could
ascertain, developed a fatal or a non-fatal
extrathymic tumour.
All but one of the remaining 383 patients
were successfully followed to December 31
1967. Some of the characteristics of these
patients are shown in Table I. More than
two-thirds were female, and about one-sixth
had a thymoma. Patients with a thymoma
were older on average at the time ofoperation
than those without.
The numbers of years that these patients
had been at risk of dying were computed
separately for those with and without
thymoma, for each sex and 5-year age group,
for each year after thymectomy, and for each
calendar vear ofobservation. Thesenumbers
were then multiplied by the corresponding
death rates for England and Wales and an
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TABLE I.-Distribution of the 382 Patients Included in the Analysis According
to Sex, Thymnic Pathology and Age at Thymectorny (percentages in parentheses)
Age at thymectomy (years)
Sex Thymic pathology Up to 19 20-39 40 or more Total
M No thymoma 14 (16-5) 47 (55 3) 24 (28 2) 85
At Thymoma 0( ) 7 (30 5) 16 (69 5) 23
F No thymoma 50(21-5) 136 (58 6) 46 (19-9) 232
F Thymoma 0 ( ) 11 (26 2) 31 (73 8) * 42
TABLE II. Observed and Expected Numbers of Deaths by (Cause According
to Sex and Thymic Pathology
Cause of death
Myasthenia or Extrathymic
thymoma tumours All other causes
Sex Thymic pathology Obs. Exp. Obs. Exp. Obs. Exp.
MI No thymoma 1 0* 0 1-96 7 6-31
I Thymoma . 14 0* 0 0*42 2 120
F No thymoma . 47 0* 5 2-60 4 4-84
F Thymoma . 24 0* 0 0 * 54 2 1 22
Total . 100 0* 5 5 - 52 15 13 - 57
* Not calculated, but approximates closely to zero.
estimate ob)tained of the numbers of deaths
that Mwould have been expected ifthe patients
had suffered the same mortality as the general
population.
RESULTS
Table II shows the observed and
expected numbers of deaths among the
382 patients up to December 31, 1967,
(i) from nmyasthenia gravis or thymoma,
(ii) from extrathymic tumours, and (iii)
from all other causes of death, classified
by the sex of the patient and the thynmic
pathology. The only major discrepancy
between the observed and the expected
numbers of deaths is the anticipated one
relating to myasthenia gravis and
thymoma. So far asextrathymic tumours
are concerned, the total of 5 observed is
almost the same as the 5-5 expected.
Table III shows how the 5 deaths
from extrathlymic tumours were distri-
buted with respect to age and interval
since thymectomy. The most notable
feature is that 3 fatalities were observed
at ages 20-39 years while only 051 would
have been expected; but with such small
numbers little weight can be attached to
this finding.
Information concerning the nature of
the 5 fatal tumours is given in Table IV,
which also provides details of 5 non-fatal
tumours diagrnosed during the follow-up
period. There is no suggestion from these
data that any particular type of tumour
tends to deveJop after thymectomy.
The full analysis of the present data
relates only to the period up to December
31, 1967, but during our enquiries we
obtained some additional information
about the progress and occurrence of
tumours in later years. First, the patient
listed as case 7 in Table IV died in May
1968; no post-mortem was held and the
site of the primary tumour was never
found. Biopsy of secondary deposits
during life showed the tumour to be
poorly differentiated with a glandular
structure in some areas. Secondly, a male
patient died from carcinoma of the
stomach in July 1969 at the age of 59
years, 13 years after a thyrnoma had been
removed. Thirdly, a female patient deve-
loped carcinoma of the breast in February
1968 at the age of 53 years, 21 years after
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TABLE III.--Nunbers of Deaths from Extrathymic Tumours Observed and Expected by
Age Groups and Interval Since Thymectomy. Patients of Both Sexes With and
Without Thymoma
Interval since thymectomy (years)
I
Age( years)
Up to 19
20-39
40-59
60 or more
Total
Up to 4
.
Obs. Exp.
0) 0.01
o} 0 18
0 0 81
0 0 22
0 1 22
5-9
Obs. Exp.
O 0 00
1 0-17
0 0 87
0 0 27
1 1-31
10-14
Obs. Exp.
0 0 00
2 0-11
2 0-91
0 0 47
4 1 49
15 or more
Obs. Exp.
0 0 00
0 0 05
0 0-85
0 0-60
0 1-50
Total
Obs. Exp.
0 0-01
3 0-51
2 3 44
0 1-56
5 5-52
TABLE IV.-Extrathyinic Tumourrs Occurring in the 382 Patients
Included in the Analysis up to December 31, 1967
Age at
Case Thymic diagnosis
number Sex pathology (years)
Fatal tumours
1 F No thymoma
2 F No thymoma
3 F No thymoma
4 F No thymoma
5 F No thymoma
Non-fatal tumours
6 M Thymoma
7 M No thymoma
8 F No thymoma
9 F Thymoma
10 F No thymoma
28
34
36
42
52
Age at
death
(years)
29
34
37
45
53
43
45
53
55
57
Interval
since
thymectomy
at
diagnosis
(years)
8
13
10
8
13
11
11
16
13
16
Nature of tumour
Hodgkins disease
Astrocytoma of spinal cord
Osteogenic sarcoma of sacrum
Carcinoma of breast
Squamous carcinoma of abd. wall*
Carcinoma of breast
Metastatic carcinoma of spinet
Chronic lymphatic leukaemia
Bronchial adenoma-carcinoid type
Pituitary adenoma
* Complicating faecal fistulae thought to be secondary to tuberculous peritonitis in early life.
t Primary never found.
thymectomy (no thymoma found).
Finally, a rodent ulcer of the nose was
diagnosed in a 60-year-old female patient
in January 1969, 26 years after thymec-
tomy (no thymoma found).
I)ISCUSSION
So far as they go, the results of the
present study do not suggest that thymec-
tomy in adult life leads to any special risk
of neoplastic disease either as a whole or
of any particular type. It should be
noted, however, (i) that observations
extending beyond 15 years after operation
are few at present, (ii) that 3 ofthe deaths
from neoplastic disease which occurred
before December 31, 1967, were in patients
under 40 years of age, and (iii) that all 13
tumours that have been observed occurred
8 or more years after thymectomy.
More prolonged follow-up of the present
series of patients is therefore desirable.
A number of papers evaluating
thymectomy as a treatment for myas-
thenia gravis have been published, con-
cerning both patients operated on in
Britain (e.g. Keynes, 1949; Simpson,
1958; Henson et al., 1965) and patients
operated on in the United States (e.g.
Eaton and (Iigett, 1950, 1955; Perlo et al.,
1966; Papatestas et al., 1]971). These
publications are oflittle help in connection
with the present problem, because none of
them includes any special analysis of
extrathymic neoplasms, and deaths are for
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the most part classified only as myasthenic
or non-myasthenic. Furthermore, it
should be noted that the major British
papers mostly relate to patients included
in the present series (Keynes, 1949;
Simpson, 1958; Henson et al., 1965). In
none of the publications, however, has it
been suggested that an undue number of
patients developed cancer either among
those subjected to thymectomy or among
those who were treated medically.
Special mention must be made of a
report by Souadjian et al. (1968). From
1925 to 1964, 213 patients seen at the
Mayo Clinic had a histologically proved
diagnosis of thymoma. Souadjian and
his colleagues obtained follow-up informa-
tion for 1]95 of these and studied 146 who
had died and had an autopsy. How many
of these patients also had mvasthenia
gravis is not stated, but presumably all of
them had a thymectomy, although this
also is not specified. Thirty-one of these
146 patients developed an extrathymic
malignant lesion. The highest incidence
of these extrathymic malignant lesions
was 10-15 years after the diagnosis of a
thymoma. Five of the 31 patients deve-
loped a lymphoma; the remaining 26
tumours affected a wide variety of organs.
For comparative purposes Souadjian and
his colleagues studied 177 patients with
parathyroid adenoma; only 15 of these
patients subsequently developed a malig-
nant neoplasm of another tissue despite
their more favourable survival experience.
These findings of Souadjian and his
colleagues are difficult to interpret.
Patients who had not died were specifically
excluded, and the analysis was not con-
ducted on a formal actuarial or person-
years at risk basis. The only information
relevant to the latter point is that 81 of
the 146 patients with a thymoma survived
more than 5 years after diagnosis. None
the less, the number ofpatients developing
extrathymic malignancies seems remark-
ably high. Our findings do not support
those of Souadjian and his colleagues, but
it should be noted that among the 65
patients with a thymoma included in the
present analvsis, less than 100 person-
years at risk 10 or more years after thy-
mectomly had accumulated by December
31, 1967. One possibility that might be
considered is that the thymectomies in our
patients were incomplete. This, however,
is not borne out by the autopsy evidence.
Of the 120 patients who died (Table II),
we were able to examine the autopsy
reports for 43. Five ofthese 43 died from
extension of a malignant thymoma, but in
none of the remaining 38 was any residual
thymic tissue noted at post-mortem.
We would like to express our gratitude
to Mrs B. Norman-Smith who was respon-
sible for tracing the patients; to Miss
E. J. Armour, Dr J. N. Blau, Mr G. F.
Flavell, Dr R. A. Henson, MrG. K. Horner,
Mr AM. J. Lange, Professor J. A. Simpson,
Dr C. Stern and Mr V. C. Thompson, all of
whom assisted in identifying patients who
had had a thymectomy to physicians and
surgeons at the National Hospital, New
End Hospital, St Bartholomew's Hospital,
and the London Hospital. for permissior
to study patients under their care; and to
Mr I. D. Hill for help with the analysis.
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